Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NPCE
#4756
Neuropace, Inc. - Common Stock
0.1
7
USD
-99.05%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.05%
Monthly Change
-99.01%
6 month change
-98.98%
Year Change
-98.44%
Previous Close
17.3
9
Open
0.1
7
Low
0.1
7
High
0.1
7
Volume
87
Markets
US Stock Market
Healthcare
NPCE
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
24.47 M
25.1 M
28.34 M
32.56 M
33.67 M
34.09 M
Valuation ratios
Enterprise value
277.33 M
82.45 M
316.11 M
410.44 M
557.01 M
636.62 M
Price to earnings ratio
-4.65
-0.75
-7.7
-12.03
-23.39
-26.73
Price to sales ratio
3.71
0.78
3.86
4.08
5.05
5.78
Price to cash flow ratio
6.81
0.96
12.83
18.16
-45.91
-61.69
Price to book ratio
2.28
1.02
12.24
40.67
26.55
8.04
Enterprise value to EBITDA ratio
-11.97
-2.05
-11.83
-19.33
-35.11
-39.17
Profitability ratios
Return on assets %
-0.27
-0.41
-0.31
-0.29
-0.2
-0.07
Return on equity %
-0.49
-1.35
-1.6
-3.39
-1.13
-0.46
Return on invested capital %
-1 195.31
-1 140.71
-494.27
-416.78
-226.06
-74.3
Gross margin %
74
71.38
73.56
73.94
77.23
81.78
Operating margin %
-52.54
-89.62
-41.54
-27.12
-16.34
-25.23
EBITDA margin %
-51.29
-88.46
-40.84
-26.58
-15.87
-24.65
Net margin %
-79.85
-103.43
-50.38
-33.97
-21.47
-30.31
Liquidity ratios
Quick ratio
13.44
8.02
5.02
4.48
4.33
4.35
Current ratio
14.28
8.9
5.71
5.37
5.28
5.38
Inventory turnover
1.5
1.49
1.65
1.69
1.35
0.24
Asset turnover
0.34
0.37
0.59
0.79
0.95
0.22
Solvency ratios
Debt to assets ratio
0.37
0.46
0.53
0.63
0.56
0.6
Debt to equity ratio
0.68
1.52
2.76
7.43
3.09
4.08
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.48
-1.5
-0.76
-0.62
-0.34
-0.28
EBIT per share
-1.43
-1.66
-1.05
-0.74
-0.5
-0.51
EBITDA per share
-1.4
-1.64
-1.03
-0.73
-0.48
-0.49
Total debt per share
3
2.15
2.2
2.04
1.8
1.75
Cash per share
6.96
3.15
2.57
1.81
1.87
1.6
Net current asset value per share
8
3.97
3.59
2.79
2.87
2.58
Tangible book value per share
4.43
1.41
0.8
0.28
0.58
0.43
Working capital per share
7.44
3.53
2.96
2.27
2.33
2.1
Book value per share
4.43
1.41
0.8
0.28
0.58
0.43
News
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
NPCE Explains How NeuroPace's RNS System Makes Money
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised
NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
Neuropace (NPCE) chief medical officer sells $399k in stock